Dr. Douglas Blayney is a professor of medicine at the Stanford University School of Medicine. His clinical interest is breast cancer, and his research focuses on quality improvement in cancer care systems, new drug development and improvement of the patient experience. Dr. Blayney received the first Ellen Stovall Award for Innovation in Patient Centered Care, National Coalition for Cancer Survivorship, and the Joseph V. Simone Award and Lecture for Excellence in Quality and Safety in the Care of Patients with Cancer, American Society of Clinical Oncology (ASCO). He is past president of the ASCO, was a founding member of the National Comprehensive Cancer Network Growth Factor Guideline panel and is a past member of the U.S. Food and Drug Administration’s Oncology Drugs Advisory Committee. Dr. Blayney has worked in academic and community practice settings, and has three daughters, one of whom is a physician. He received training at Stanford University, University of California at San Diego, and the National Cancer Institute.